1
|
Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.
|
Clin Cancer Res
|
2011
|
1.35
|
2
|
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.
|
Cancer
|
2010
|
1.04
|
3
|
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma.
|
Lung Cancer
|
2011
|
1.03
|
4
|
Second-line treatment for malignant pleural mesothelioma.
|
Cancer Treat Rev
|
2009
|
0.94
|
5
|
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
|
Eur J Cancer
|
2012
|
0.86
|
6
|
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.79
|
7
|
Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
|
J Clin Oncol
|
2011
|
0.77
|
8
|
Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.
|
Future Oncol
|
2015
|
0.77
|